Longevity startup Vesalius goes public via reverse takeover in Vancouver
What's the deal? Vesalius Longevity Labs has completed its reverse takeover of Sweet Earth Holdings CorporationDealroom has a profile for this one. Try Dealroom →, creating a single public company that will trade on the Canadian Securities Exchange under the ticker "VLAB". The now-combined entity, renamed Vesalius Longevity Labs Inc., closed the transaction on October 29, 2026.
How it works: The deal was structured as a statutory amalgamation under British Columbia law, folding Vesalius Longevity Labs (Canada) Inc. and a related entity, Vesalius Longevity Labs (SPV) Inc., into the listed shell. Former Vesalius Canada shareholders exchanged two shares for one Company Share; SPV holders swapped at a one-for-one rate.
By the numbers: There are now 100,828,947 shares outstanding, or 117,063,697 on a fully diluted basis. Former Vesalius Canada holders control roughly 41.86% of the diluted shares, while SPV holders hold about 29.91%.
Why now? The combination was first announced in March 2025 and amended several times before closing. Trading in the shares has been halted since June 17, 2025, and is expected to resume under the new "VLAB" symbol once a listing date is set.
What's locked up? Related persons deposited 19,250,000 shares into escrow, with 10% released on the listing date and 15% every six months after. A further 49,000,000 shares held by former Vesalius Canada shareholders face staggered resale restrictions tied to the listing date.
The signal: A reverse takeover offers startups a faster route to public markets than a traditional IPO, and the CSE has become a common venue for smaller issuers to list. For Vesalius, the close turns a longevity venture into a trading company — with roughly US$6.5 million in cash on its balance sheet to work with.
Read more: ca.finance.yahoo.com
Image credit: Generated with Gemini
